| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.02 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.02 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.03 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.1 | 0.04 |